Correlation Between Enanta Pharmaceuticals and Bausch Health

Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Bausch Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Bausch Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enanta Pharmaceuticals and Bausch Health Companies, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Bausch Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Bausch Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Bausch Health.

Diversification Opportunities for Enanta Pharmaceuticals and Bausch Health

-0.42

Correlation Coefficient

Enanta Pharmaceuticals  Bausch Health

Very good diversification

The 3 months correlation between Enanta and Bausch is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Bausch Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Bausch Health go up and down completely randomly.

Pair Corralation between Enanta Pharmaceuticals and Bausch Health

Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Bausch Health. In addition to that, Enanta Pharmaceuticals is 1.17 times more volatile than Bausch Health Companies. It trades about -0.5 of its total potential returns per unit of risk. Bausch Health Companies is currently generating about -0.23 per unit of volatility. If you would invest  926.00  in Bausch Health Companies on September 3, 2024 and sell it today you would lose (89.00) from holding Bausch Health Companies or give up 9.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Enanta Pharmaceuticals  vs.  Bausch Health Companies

Enanta Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enanta Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bausch Health Companies

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enanta Pharmaceuticals and Bausch Health

The main advantage of trading using opposite Enanta Pharmaceuticals and Bausch Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Bausch Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will offset losses from the drop in Bausch Health's long position.

The idea behind Enanta Pharmaceuticals and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .